Bausch + Lomb Receives European CE Mark for Next-Generation SeeLyra Femtosecond Laser
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a global eye health company focused on helping people see better and live better, has announced that its next-generation SeeLyra femtosecond laser has received European CE Mark approval. The regulatory milestone advances the company’s latest surgical laser platform toward commercialization in Europe and expands its portfolio of technologies designed to support ophthalmic surgeons across a range of procedures.
SeeLyra has been developed as a compact femtosecond laser platform intended to provide surgeons with precision, control and flexibility during laser preparation for premium cataract surgery, LASIK flap creation and corneal therapeutic procedures. The system is designed to combine advanced visualization and laser control capabilities with a compact footprint and workflow features intended to support the demands of modern operating rooms.
Bausch + Lomb expects to make SeeLyra available on a limited basis in selected European markets in the coming months, with broader availability anticipated in 2027. The company is also pursuing regulatory approvals for the platform in other markets around the world, including the United States. Product indications and regulatory approvals may vary depending on the country.
New Generation of Femtosecond Laser Technology
SeeLyra represents the latest development in Bausch + Lomb’s femtosecond laser portfolio and builds on the company’s more than 15 years of experience in the femtocataract laser market.
Femtosecond laser technology has become an important component of advanced ophthalmic surgery, allowing surgeons to perform highly precise laser-assisted steps in procedures that traditionally relied more heavily on manual techniques. In cataract surgery, for example, femtosecond lasers can be used for specific stages of surgical preparation, while in refractive surgery they can support the creation of corneal flaps.
Bausch + Lomb designed SeeLyra to address both the technical requirements of these procedures and the practical realities of contemporary operating rooms. Hospitals and ambulatory surgical centers increasingly need equipment that can provide sophisticated capabilities without occupying excessive space or creating unnecessary workflow complexity.
According to the company, SeeLyra is one of the most compact femtosecond platforms available and has been designed to provide greater flexibility in how it is positioned and used within the operating environment.
Luc Bonnefoy, president of Surgical at Bausch + Lomb, said the company’s objective was to build on its extensive experience in femtocataract lasers while delivering a platform with enhanced functionality and greater operating-room flexibility.
He said SeeLyra is designed to provide surgeons with the precise preparation and controlled conditions needed for premium cataract procedures while maintaining space efficiency and supporting efficient workflows.
Real-Time OCT Visualization
One of the key technologies incorporated into SeeLyra is live swept-source optical coherence tomography (OCT). The system provides real-time visualization of tissue depth during the procedure, helping surgeons monitor the surgical environment while positioning and applying the laser.
Real-time imaging can play an important role in procedures where accurate positioning of laser cuts is critical. SeeLyra’s OCT capabilities are intended to help reduce variability during docking and support precise positioning of laser cuts.
The technology also provides visual control during laser application, giving surgeons additional information as they perform the planned treatment.
By integrating visualization directly into the femtosecond laser platform, Bausch + Lomb aims to provide surgeons with a more controlled and consistent workflow. The ability to visualize relevant anatomical structures and depth information during the procedure can support surgical planning and execution, particularly in procedures requiring precision.
For premium cataract surgery, where patient expectations and surgical precision are particularly important, the company believes these capabilities can help support consistent preparation of the eye before subsequent surgical steps.
Designed for Multiple Ophthalmic Procedures
SeeLyra is not limited to a single procedure. The platform is designed to support a range of ophthalmic applications, including cataract surgery, LASIK flap creation and corneal therapeutic treatments.
This versatility is intended to make the system useful across different surgical needs and potentially allow facilities to consolidate multiple femtosecond laser applications on a single platform.
The system retains several features associated with Bausch + Lomb’s previous-generation VICTUS™ femtosecond platform. These include an intuitive user interface designed to simplify system setup and support adaptability across different procedures.
Building on an existing platform can also help provide familiarity for surgeons and operating-room staff who have experience with Bausch + Lomb’s femtosecond laser technology.
The company’s objective is to combine established functionality with new capabilities that can improve visualization, positioning and operating-room flexibility.
Compact Design for Modern Operating Rooms
Space efficiency is another central feature of SeeLyra. Modern operating rooms can be highly constrained environments, with multiple pieces of surgical and diagnostic equipment competing for available space.
SeeLyra has been designed without a fixed patient bed, allowing the platform to be positioned more flexibly within the operating room. The system is also compatible with existing bed setups, which can make it easier to integrate into facilities with established surgical configurations.
The absence of a dedicated fixed bed may provide additional operational flexibility while also supporting patient comfort. According to Bausch + Lomb, patients do not need to switch beds between procedures when SeeLyra is integrated with existing bed configurations.
The system’s mobility also allows it to be transported more easily within modern surgical environments, potentially supporting facilities that need to use operating-room space efficiently.
Another feature is an articulating swing arm, which is designed to accommodate surgeons’ preferred orientation during surgery. This provides additional flexibility in how the system is positioned relative to the surgeon and patient.
Supporting Premium Cataract Surgery
Premium cataract surgery continues to evolve as surgeons adopt technologies designed to provide greater precision and support improved visual outcomes. Surgical preparation is a critical part of this process, and femtosecond laser technology can assist with specific steps of the procedure.
Bausch + Lomb believes SeeLyra can support this segment by combining precise laser preparation with real-time imaging and a flexible operating-room design.
José Manuel Larrosa, MD, of the University of Zaragoza in Spain, emphasized the importance of precision during surgical preparation. He said SeeLyra is designed to help surgeons achieve consistent preparation while fitting efficiently into operating-room space and workflow requirements.
The platform’s ability to support multiple procedures may also make it attractive to surgical centers seeking flexible technology that can be deployed across different ophthalmic applications.
Balancing Precision With Workflow Efficiency
As surgical technologies become more sophisticated, hospitals and surgeons increasingly consider not only clinical functionality but also the impact of equipment on workflow.
A highly capable device may create challenges if it requires extensive setup, occupies substantial space or disrupts existing operating-room processes. Bausch + Lomb has therefore designed SeeLyra around both surgical precision and operational efficiency.
The company says the platform’s compact architecture, flexible positioning, compatibility with existing bed configurations and intuitive interface are intended to reduce some of the practical barriers associated with integrating advanced femtosecond laser technology into modern surgical environments.
The system’s live OCT imaging adds another layer of functionality by providing real-time depth visualization during laser preparation.
Together, these features are intended to create a platform that can support surgeons without requiring them to substantially change their preferred surgical environment.
Building on VICTUS Experience
SeeLyra also represents an evolution of Bausch + Lomb’s experience with the VICTUS femtosecond platform. The company has incorporated features from its previous system while developing additional functionality for the new generation.
Maintaining a familiar interface can be particularly important for ophthalmic surgeons and surgical staff who have already developed workflows around existing technology. By retaining key elements of the VICTUS platform while introducing new capabilities, Bausch + Lomb aims to facilitate adoption of SeeLyra.
The company’s more than 15 years of experience in the femtocataract laser market also provides a foundation for the new platform as it enters European markets.
European Launch Planned
Following the CE Mark approval, Bausch + Lomb plans to introduce SeeLyra in selected European markets on a limited basis in the coming months. Increasing availability is expected during 2027.
The company is also pursuing regulatory approvals in additional global markets, including the United States. The timing and scope of availability will depend on individual regulatory requirements, and product indications may differ between countries.
The European CE Mark represents an important step in the commercialization process, but it does not mean the platform has received approval for every indication or market worldwide. Bausch + Lomb will continue working with regulators in other jurisdictions as it seeks to expand access to the technology.
Advancing Ophthalmic Surgical Technology
The introduction of SeeLyra reflects Bausch + Lomb’s broader focus on developing technologies that combine surgical precision with practical improvements in operating-room efficiency.
With live swept-source OCT, a compact design, flexible positioning, an articulating swing arm and compatibility with existing bed configurations, SeeLyra is designed to address both the clinical and operational demands of modern ophthalmic surgery.
The platform’s ability to support cataract, LASIK flap and corneal therapeutic procedures further expands its potential utility across different areas of eye surgery.
For surgeons, the company aims to provide greater control over laser preparation and real-time visualization while preserving flexibility in the operating environment. For surgical centers, the compact configuration and mobility may offer advantages in facilities where space and workflow efficiency are important considerations.
With European CE Mark approval now secured, Bausch + Lomb is moving toward the commercial introduction of SeeLyra in selected European markets. As availability expands during 2027 and the company pursues additional regulatory approvals worldwide, including in the United States, SeeLyra will become an important addition to Bausch + Lomb’s ophthalmic surgical technology portfolio.
The company’s latest platform ultimately reflects an effort to combine the precision of femtosecond laser technology with real-time imaging and a more adaptable operating-room design, supporting the continued evolution of cataract, refractive and corneal surgery.
About Bausch + Lomb
Our mission is simple – we help people see better to live better, all over the world. For nearly two centuries we’ve evolved with the changing needs of patients and customers, and our commitment to innovation and improving the standard of care in eye health has never been stronger. From contact lenses to prescription products, over-the-counter options, surgical devices and more, we’re turning bold ideas into better outcomes through passion, perseverance and purpose.